Doseology Sciences Inc. (MOOD.CN)
CAD 0.15
(0.0%)
CAD 0.15
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 98.52 Thousand | 43.08 Thousand | 16.04 Thousand | - | - |
| Cost of Revenue | 134.6 Thousand | 1802.00 | 164.42 Thousand | - | - |
| Gross Profit | -36.08 Thousand | 41.28 Thousand | -148.37 Thousand | - | - |
| Operating Expenses | 72.08 Thousand | 873.45 Thousand | 1.66 Million | 1.56 Million | 431.63 Thousand |
| Selling, General and Administrative Expenses | 349.93 Thousand | 759.77 Thousand | 1.46 Million | 1.36 Million | 431.63 Thousand |
| Research and Development Expenses | - | 500.00 | 61.72 Thousand | 112.4 Thousand | - |
| Other Expenses | - | 190.89 Thousand | 139.53 Thousand | - | - |
| Cost and Expenses | 476.15 Thousand | 875.26 Thousand | 1.83 Million | 1.56 Million | 431.63 Thousand |
| Operating Income | -377.63 Thousand | -767.13 Thousand | -1.81 Million | -1.56 Million | -431.63 Thousand |
| Interest Expense | - | 36.13 Thousand | 75.77 Thousand | 68.29 Thousand | - |
| Income Tax Expense | - | 36.13 Thousand | 75.77 Thousand | 68.29 Thousand | - |
| Earnings before Tax | -339.84 Thousand | -1.78 Million | -1.93 Million | -1.62 Million | -431.63 Thousand |
| Net Income | -339.84 Thousand | -1.78 Million | -1.93 Million | -1.62 Million | -431.63 Thousand |
| Earnings Per Share Basic | -0.08 | -0.43 | -0.50 | - | -0.12 |
| Earnings Per Share Diluted | -0.08 | -0.43 | -0.50 | - | -0.12 |
| Weighted Average Shares Outstanding | 4.26 Million | 4.11 Million | 3.9 Million | - | 3.7 Million |
| Weighted Average Shares Outstanding (Diluted) | 4.26 Million | 4.11 Million | 3.9 Million | - | 3.7 Million |
| Gross Margin | -0.37 | 0.96 | -9.25 | - | - |
| EBIT Margin | -3.24 | -16.27 | -104.08 | - | - |
| Profit Margin | -3.45 | -41.35 | -120.85 | - | - |
| EBITDA | -319.47 Thousand | -1.77 Million | -1.72 Million | -1.46 Million | -431.63 Thousand |
| Earnings Before Tax Margin | -3.83 | -17.80 | -113.20 | - | - |
| Breakdown | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 FY |
|---|---|---|---|---|---|---|
| Revenue | 5296.00 | 33.85 Thousand | 13.27 Thousand | 46.1 Thousand | 11.05 Thousand | 43.08 Thousand |
| Cost of Revenue | -13.2 Thousand | 60.17 Thousand | 20.47 Thousand | 17.28 Thousand | -27.28 Thousand | 1802.00 |
| Gross Profit | 18.5 Thousand | -26.32 Thousand | -7201.00 | 28.81 Thousand | 38.34 Thousand | 41.28 Thousand |
| Operating Expenses | 125.1 Thousand | 21.4 Thousand | 131.66 Thousand | 113.24 Thousand | 130.79 Thousand | 873.45 Thousand |
| Selling, General and Administrative Expenses | 125.1 Thousand | 21.4 Thousand | 131.66 Thousand | 80.91 Thousand | 229.18 Thousand | - |
| Research and Development Expenses | - | - | - | - | 500.00 | - |
| Other Expenses | - | 22.33 Thousand | - | - | - | - |
| Cost and Expenses | 111.9 Thousand | 81.58 Thousand | 152.14 Thousand | 130.52 Thousand | 103.5 Thousand | 875.26 Thousand |
| Operating Income | -106.6 Thousand | -47.73 Thousand | -138.87 Thousand | -78.08 Thousand | -96.36 Thousand | -767.13 Thousand |
| Interest Expense | - | - | - | - | -18.54 Thousand | 36.13 Thousand |
| Income Tax Expense | -2977.00 | 3.00 | 3.00 | 6344.00 | 65.98 Thousand | 36.13 Thousand |
| Earnings before Tax | -109.58 Thousand | -40.53 Thousand | -111.64 Thousand | -78.08 Thousand | -1.05 Million | -1.78 Million |
| Net Income | -109.58 Thousand | -40.53 Thousand | -111.64 Thousand | -78.08 Thousand | -1.14 Million | -1.78 Million |
| Earnings Per Share Basic | -0.02 | -0.01 | -0.03 | -0.02 | -0.28 | - |
| Earnings Per Share Diluted | -0.02 | -0.01 | -0.03 | -0.02 | -0.28 | - |
| Weighted Average Shares Outstanding | 4.4 Million | 4.61 Million | 4.4 Million | 4.11 Million | 4.11 Million | 4.11 Million |
| Weighted Average Shares Outstanding (Diluted) | 4.4 Million | 4.61 Million | 4.4 Million | 4.11 Million | 4.11 Million | 4.11 Million |
| Gross Margin | 3.49 | -0.78 | -0.54 | 0.63 | 3.47 | 0.96 |
| EBIT Margin | -20.54 | -1.39 | -10.40 | -1.30 | -10.36 | - |
| Profit Margin | -20.69 | -1.20 | -8.41 | -1.69 | -103.72 | -41.35 |
| EBITDA | -108.78 Thousand | -46.93 Thousand | -138.07 Thousand | -60.1 Thousand | -114.6 Thousand | - |
| Earnings Before Tax Margin | -20.13 | -1.41 | -10.46 | -1.69 | -8.71 | -17.80 |
SYM
ZRVT
600962
FSNUY
6093
4960